-
1
-
-
0001843697
-
Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the US population
-
Clark JM, Brancati FL, Diehl AME. Nonalcoholic fatty liver disease: the most common cause of abnormal liver enzymes in the US population. Gastroenterology. 2011;120(5 Suppl 1):A65.
-
(2011)
Gastroenterology
, vol.120
, Issue.5
, pp. A65
-
-
Clark, J.M.1
Brancati, F.L.2
Diehl, A.M.E.3
-
2
-
-
84861543083
-
The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
-
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-23.
-
(2012)
Hepatology
, vol.55
, Issue.6
, pp. 2005-2023
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
Diehl, A.M.4
Brunt, E.M.5
Cusi, K.6
-
3
-
-
33847629709
-
Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease
-
Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007;30:734-43.
-
(2007)
Diabetes Care.
, vol.30
, pp. 734-743
-
-
Tolman, K.G.1
Fonseca, V.2
Dalpiaz, A.3
Tan, M.H.4
-
4
-
-
84927796763
-
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management
-
McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2015;62(5):1148-55.
-
(2015)
J Hepatol
, vol.62
, Issue.5
, pp. 1148-1155
-
-
McPherson, S.1
Hardy, T.2
Henderson, E.3
Burt, A.D.4
Day, C.P.5
Anstee, Q.M.6
-
5
-
-
11144351102
-
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
-
Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 2005;42:132-8.
-
(2005)
J Hepatol.
, vol.42
, pp. 132-138
-
-
Adams, L.A.1
Sanderson, S.2
Lindor, K.D.3
Angulo, P.4
-
6
-
-
79961218135
-
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies
-
Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer. 2012;130(7):1639-48.
-
(2012)
Int J Cancer
, vol.130
, Issue.7
, pp. 1639-1648
-
-
Wang, C.1
Wang, X.2
Gong, G.3
Ben, Q.4
Qiu, W.5
Chen, Y.6
-
7
-
-
84960447390
-
Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases
-
Raff EJ, Kakati D, Bloomer JR, Shoreibah M, Rasheed K, Singal AK. Diabetes mellitus predicts occurrence of cirrhosis and hepatocellular cancer in alcoholic liver and non-alcoholic fatty liver diseases. J Clin Transl Hepatol. 2015;3(1):9-16.
-
(2015)
J Clin Transl Hepatol
, vol.3
, Issue.1
, pp. 9-16
-
-
Raff, E.J.1
Kakati, D.2
Bloomer, J.R.3
Shoreibah, M.4
Rasheed, K.5
Singal, A.K.6
-
8
-
-
84962089316
-
Metabolic impact of nonalcoholic steatohepatitis in obese patients with type 2 diabetes
-
Lomonaco R, Bril F, Portillo-Sanchez P, Ortiz-Lopez C, Orsak B, Biernacki D, Lo M, Suman A, Weber MH, Cusi K. Metabolic impact of nonalcoholic steatohepatitis in obese patients with type 2 diabetes. Diabetes Care. 2016;39(4):632-8.
-
(2016)
Diabetes Care
, vol.39
, Issue.4
, pp. 632-638
-
-
Lomonaco, R.1
Bril, F.2
Portillo-Sanchez, P.3
Ortiz-Lopez, C.4
Orsak, B.5
Biernacki, D.6
Lo, M.7
Suman, A.8
Weber, M.H.9
Cusi, K.10
-
9
-
-
84942107494
-
Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes
-
Mantovani A, Pernigo M, Bergamini C, Bonapace S, Lipari P, Pichiri I, et al. Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes. PLoS One. 2015;10(8):e0135329.
-
(2015)
PLoS One
, vol.10
, Issue.8
-
-
Mantovani, A.1
Pernigo, M.2
Bergamini, C.3
Bonapace, S.4
Lipari, P.5
Pichiri, I.6
-
10
-
-
84958764638
-
Non-alcoholic fatty liver disease is a risk factor for the development of diabetic nephropathy in patients with type 2 diabetes mellitus
-
Jia G, Di F, Wang Q, Shao J, Gao L, Wang L, et al. Non-alcoholic fatty liver disease is a risk factor for the development of diabetic nephropathy in patients with type 2 diabetes mellitus. PLoS One. 2015;10(11):e0142808.
-
(2015)
PLoS One
, vol.10
, Issue.11
-
-
Jia, G.1
Di, F.2
Wang, Q.3
Shao, J.4
Gao, L.5
Wang, L.6
-
11
-
-
39049102073
-
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients
-
Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia. 2008;51(3):444-50.
-
(2008)
Diabetologia
, vol.51
, Issue.3
, pp. 444-450
-
-
Targher, G.1
Bertolini, L.2
Rodella, S.3
Zoppini, G.4
Lippi, G.5
Day, C.6
-
12
-
-
34247605492
-
Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients
-
Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30(5):1212-8.
-
(2007)
Diabetes Care
, vol.30
, Issue.5
, pp. 1212-1218
-
-
Targher, G.1
Bertolini, L.2
Padovani, R.3
Rodella, S.4
Tessari, R.5
Zenari, L.6
-
13
-
-
77957375969
-
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
-
Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010;363:1341-50.
-
(2010)
N Engl J Med.
, vol.363
, pp. 1341-1350
-
-
Targher, G.1
Day, C.P.2
Bonora, E.3
-
14
-
-
84904395126
-
Modern approach to the clinical management of non-alcoholic fatty liver disease
-
Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol. 2014;20(26):8341-50.
-
(2014)
World J Gastroenterol
, vol.20
, Issue.26
, pp. 8341-8350
-
-
Ben, M.1
Polimeni, L.2
Baratta, F.3
Pastori, D.4
Loffredo, L.5
Angelico, F.6
-
15
-
-
40749094549
-
25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age
-
Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age. Diabetes. 2008;57(2):298-305.
-
(2008)
Diabetes
, vol.57
, Issue.2
, pp. 298-305
-
-
Hypponen, E.1
Boucher, B.J.2
Berry, D.J.3
Power, C.4
-
16
-
-
58149346072
-
Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000
-
Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57:2619-25.
-
(2008)
Diabetes.
, vol.57
, pp. 2619-2625
-
-
Forouhi, N.G.1
Luan, J.2
Cooper, A.3
Boucher, B.J.4
Wareham, N.J.5
-
17
-
-
84881159298
-
Hypovitaminosis D is independently associated with metabolic syndrome in obese patients
-
Barchetta I, De Bernardinis M, Capoccia D, Baroni MG, Fontana M, Fraioli A, et al. Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS One. 2013;8(7):e68689.
-
(2013)
PLoS One
, vol.8
, Issue.7
-
-
Barchetta, I.1
Bernardinis, M.2
Capoccia, D.3
Baroni, M.G.4
Fontana, M.5
Fraioli, A.6
-
18
-
-
34547485376
-
Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease
-
Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517-24.
-
(2007)
Nutr Metab Cardiovasc Dis
, vol.17
, Issue.7
, pp. 517-524
-
-
Targher, G.1
Bertolini, L.2
Scala, L.3
Cigolini, M.4
Zenari, L.5
Falezza, G.6
-
19
-
-
79960152007
-
Strong association between nonalcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes
-
Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, et al. Strong association between nonalcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85.
-
(2011)
BMC Med.
, vol.9
, pp. 85
-
-
Barchetta, I.1
Angelico, F.2
Ben, M.3
Baroni, M.G.4
Pozzilli, P.5
Morini, S.6
-
20
-
-
84879735651
-
Meta-analysis: vitamin D and non-alcoholic fatty liver disease
-
Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38:246-54.
-
(2013)
Aliment Pharmacol Ther.
, vol.38
, pp. 246-254
-
-
Eliades, M.1
Spyrou, E.2
Agrawal, N.3
Lazo, M.4
Brancati, F.L.5
Potter, J.J.6
-
21
-
-
84904410617
-
Vitamin D and adipose tissue-more than storage
-
Mutt SJ, Hyppönen E, Saarnio J, Järvelin MR, Herzig KH. Vitamin D and adipose tissue-more than storage. Front Physiol. 2014;5:228.
-
(2014)
Front Physiol.
, vol.5
, pp. 228
-
-
Mutt, S.J.1
Hyppönen, E.2
Saarnio, J.3
Järvelin, M.R.4
Herzig, K.H.5
-
22
-
-
84870563131
-
Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus
-
Barchetta I, Carotti S, Labbadia G, Gentilucci UV, Muda AO, Angelico F, et al. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology. 2012;56(6):2180-7.
-
(2012)
Hepatology
, vol.56
, Issue.6
, pp. 2180-2187
-
-
Barchetta, I.1
Carotti, S.2
Labbadia, G.3
Gentilucci, U.V.4
Muda, A.O.5
Angelico, F.6
-
23
-
-
53349142350
-
1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells
-
Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diab Metab Res Rev. 2004;24:459-64.
-
(2004)
Diab Metab Res Rev.
, vol.24
, pp. 459-464
-
-
Zhou, Q.G.1
Hou, F.F.2
Guo, Z.J.3
Liang, M.4
Wang, G.B.5
Zhang, X.6
-
24
-
-
80655127773
-
Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats
-
Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Tov AB, Brazowski E, et al. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut. 2011;60:1728-37.
-
(2011)
Gut.
, vol.60
, pp. 1728-1737
-
-
Abramovitch, S.1
Dahan-Bachar, L.2
Sharvit, E.3
Weisman, Y.4
Tov, A.B.5
Brazowski, E.6
-
25
-
-
84866382064
-
D-livering the message: the importance of vitamin D status in chronic liver disease
-
Kitson MT, Roberts SK. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol. 2012;57(4):897-909.
-
(2012)
J Hepatol
, vol.57
, Issue.4
, pp. 897-909
-
-
Kitson, M.T.1
Roberts, S.K.2
-
26
-
-
70350046669
-
Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study
-
Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology. 2009;50:1072-8.
-
(2009)
Hepatology.
, vol.50
, pp. 1072-1078
-
-
Feldstein, A.E.1
Wieckowska, A.2
Lopez, A.R.3
Liu, Y.C.4
Zein, N.N.5
McCullough, A.J.6
-
27
-
-
84856388968
-
Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis
-
Joka D, Wahl K, Moeller S, Schlue J, Vaske B, Bahr MJ, et al. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology. 2012;55:455-64.
-
(2012)
Hepatology.
, vol.55
, pp. 455-464
-
-
Joka, D.1
Wahl, K.2
Moeller, S.3
Schlue, J.4
Vaske, B.5
Bahr, M.J.6
-
28
-
-
84930179342
-
A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet
-
Han H, Cui M, You X, Chen M, Piao X, Jin G. A role of 1,25(OH)2D3 supplementation in rats with nonalcoholic steatohepatitis induced by choline-deficient diet. Nutr Metab Cardiovasc Dis. 2015;25(6):556-61.
-
(2015)
Nutr Metab Cardiovasc Dis
, vol.25
, Issue.6
, pp. 556-561
-
-
Han, H.1
Cui, M.2
You, X.3
Chen, M.4
Piao, X.5
Jin, G.6
-
29
-
-
84940062431
-
High-dose vitamin D supplementation and liver histology in NASH
-
Kitson MT, Pham A, Gordon A, Kemp W, Roberts SK. High-dose vitamin D supplementation and liver histology in NASH. Gut. 2016;65(4):717-8.
-
(2016)
Gut
, vol.65
, Issue.4
, pp. 717-718
-
-
Kitson, M.T.1
Pham, A.2
Gordon, A.3
Kemp, W.4
Roberts, S.K.5
-
30
-
-
63149173251
-
Standards of medical care in diabetes--2009
-
American Diabetes Association. Standards of medical care in diabetes--2009. Diabetes Care. 2009;32:S13-61.
-
(2009)
Diabetes Care
, vol.32
, pp. S13-61
-
-
-
31
-
-
84872133663
-
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
-
Tanwar S, Trembling PM, Guha IN, Parkes J, Kaye P, Burt AD, et al. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. Hepatology. 2013;57(1):103-11.
-
(2013)
Hepatology
, vol.57
, Issue.1
, pp. 103-111
-
-
Tanwar, S.1
Trembling, P.M.2
Guha, I.N.3
Parkes, J.4
Kaye, P.5
Burt, A.D.6
-
32
-
-
84885020653
-
Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe
-
Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, Feskens EJ, Gallagher CJ, Hypponen E, et al. Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int. 2013;24(5):1567-77.
-
(2013)
Osteoporos Int
, vol.24
, Issue.5
, pp. 1567-1577
-
-
Brouwer-Brolsma, E.M.1
Bischoff-Ferrari, H.A.2
Bouillon, R.3
Feskens, E.J.4
Gallagher, C.J.5
Hypponen, E.6
-
33
-
-
84862501520
-
Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance
-
Deleskog A, Hilding A, Brismar K, Hamsten A, Efendic S, Östenson CG. Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia. 2012;55(6):1668-78.
-
(2012)
Diabetologia
, vol.55
, Issue.6
, pp. 1668-1678
-
-
Deleskog, A.1
Hilding, A.2
Brismar, K.3
Hamsten, A.4
Efendic, S.5
Östenson, C.G.6
-
34
-
-
0032821965
-
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
-
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-70.
-
(1999)
Diabetes Care.
, vol.22
, pp. 1462-1470
-
-
Matsuda, M.1
DeFronzo, R.A.2
-
35
-
-
70350064027
-
Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis
-
Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, et al. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology. 2009;50(4):1087-93.
-
(2009)
Hepatology
, vol.50
, Issue.4
, pp. 1087-1093
-
-
Gastaldelli, A.1
Harrison, S.A.2
Belfort-Aguilar, R.3
Hardies, L.J.4
Balas, B.5
Schenker, S.6
-
36
-
-
33751246499
-
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
-
Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.
-
(2006)
BMC Gastroenterol.
, vol.6
, pp. 33
-
-
Bedogni, G.1
Bellentani, S.2
Miglioli, L.3
Masutti, F.4
Passalacqua, M.5
Castiglione, A.6
-
37
-
-
64949095273
-
Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T
-
Yokoo T, Bydder M, Hamilton G, Middleton MS, Gamst AC, Wolfson T, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology. 2009;251(1):67-76.
-
(2009)
Radiology
, vol.251
, Issue.1
, pp. 67-76
-
-
Yokoo, T.1
Bydder, M.2
Hamilton, G.3
Middleton, M.S.4
Gamst, A.C.5
Wolfson, T.6
-
38
-
-
20444362348
-
Estimates of optimal vitamin D status
-
Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713-6.
-
(2005)
Osteoporos Int
, vol.16
, Issue.7
, pp. 713-716
-
-
Dawson-Hughes, B.1
Heaney, R.P.2
Holick, M.F.3
Lips, P.4
Meunier, P.J.5
Vieth, R.6
-
39
-
-
84906940023
-
Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial
-
Sharifi N, Amani R, Hajiani E, Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine. 2014;47(1):70-80.
-
(2014)
Endocrine
, vol.47
, Issue.1
, pp. 70-80
-
-
Sharifi, N.1
Amani, R.2
Hajiani, E.3
Cheraghian, B.4
-
40
-
-
84922227008
-
Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis
-
Bril F, Maximos M, Portillo-Sanchez P, Biernacki D, Lomonaco R, Subbarayan S, et al. Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. J Hepatol. 2015;62(2):405-11.
-
(2015)
J Hepatol
, vol.62
, Issue.2
, pp. 405-411
-
-
Bril, F.1
Maximos, M.2
Portillo-Sanchez, P.3
Biernacki, D.4
Lomonaco, R.5
Subbarayan, S.6
-
41
-
-
84954479817
-
Severe vitamin D deficiency is not associated with liver damage in morbidly obese patients
-
[Epub ahead of print]
-
Anty R, Hastier A, Canivet CM, Patouraux S, Schneck AS, Ferrari-Panaia P, Ben-Amor I, Saint-Paul MC, Gugenheim J, Gual P, Iannelli A, Tran A. Severe vitamin D deficiency is not associated with liver damage in morbidly obese patients. Obes Surg. 2016. [Epub ahead of print].
-
(2016)
Obes Surg
-
-
Anty, R.1
Hastier, A.2
Canivet, C.M.3
Patouraux, S.4
Schneck, A.S.5
Ferrari-Panaia, P.6
Ben-Amor, I.7
Saint-Paul, M.C.8
Gugenheim, J.9
Gual, P.10
Iannelli, A.11
Tran, A.12
|